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vention was significantly higher in patients with CTD
(P.01). One, 5 and 10 year survival rates were 95.8%,
91.6%, and 86.1% respectively.
Conclusions: Young patients who undergo open
TAAA repair have favorable short and long-term outcomes.
However, a significant proportion require further aortic
intervention and imaging surveillance is advised, especially
in those with CTD.
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Objectives: Traumatic transection of the thoracic aorta
is being treated increasingly with the use of aortic stent
grafting. Unfortunately, most stent grafts are designed for
treating aortic aneurysmal disease instead of traumatic in-
jury. Further refinements in stent graft technology depend
on a thorough anatomic understanding of the transection
process.
Methods: All patients with computed tomography ev-
idence of blunt aortic injury between 2003 and 2011 were
queried. Their initial scans were imported into the Intu-
ition (Terarecon, Inc) viewing program, and off-line cen-
terline reconstruction was performed. Standard demo-
graphic data was collected in addition to anatomic
characteristics, including aortic diameters and relation of
the injury to the arch vessels.
Results: 52 patients were identified. Only 2 patients
had evidence of injury proximal to the left subclavian artery.
The average length from the left subclavian artery to the
proximal site of injury was 16.2 mm (range 2-31 mm).
Most patients (40) had more than 15 mm of landing zone
beyond the left subclavian artery. The range of proximal
diameters ranged from 19-32 mm, with an average aortic
diameter of 23.7 mm. Five patients had aortic diameters
smaller than 21 mm, and five patients had aortic diameters
greater than 26 mm. The average length of injured aortic
segment was 27 mm.
Conclusions: In this contemporary series from a large
trauma center, 98% of patients are anatomically able to be
treated with a stent graft that does not require coverage of the
left common carotid artery. Furthermore, 80% of patients
were anatomically able to be treated without left subclavian
artery coverage. Most patients have an aortic diameter that
falls between 21 and 26 mm in diameter as well as a short
segment of injured artery. Centers interested in emergently
treating aortic transections are able to do so while main-
taining a limited stock of stent grafts that can be used to
treat the majority of the population.
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Objectives: Prior studies examining gender differences
in AAA repair suggest there may be differences in presen-
tation, suitability for EVAR, and outcomes between men
and women.
Methods: We used the Vascular Study Group of New
England database to identify all patients undergoing EVAR
or open AAA repair (OAR). We analyzed demographics,
comorbidities, and procedural, and perioperative data. Re-
sults were compared using Fisher’s exact test.
Results: 4,193 patients underwent AAA repair (78%
male, 54% EVAR). Women were less likely to undergo
EVAR for intact aneurysms (50% vs. 60% of, P.001) but
not for ruptured aneurysms (27% vs. 21%, P.25). Women
were older (74 years vs. 72 years for intact, P.001; 77.5
years vs. 73 years for rupture, P.001) with smaller aortic
diameters (56mm vs. 59mm for elective, P.001; 71mm
vs. 78mm for rupture, P.005). Women had higher 30-
day mortality after OAR for both intact (4% vs. 2%, P.05)
and rupture (48% vs. 33%, P.03) repairs. However, 30-
day mortality after EVAR was similar for both intact (1% in
men vs. 1% in women, P.58) and rupture (29% in men vs.
26% in women, P1.00) repairs.
Conclusions: Women are undergoing EVAR at a
higher rate than previously reported, being treated at older
ages and smaller diameters, and rupture at smaller diame-
ters than men. Thirty-day mortality is worse in women after
OAR but comparable after EVAR.
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Objectives: To review clinical outcomes of endovascu-
lar treatment of type B aortic dissection.
Methods: All patients treated for type B aortic dissec-
tion between 2006-2011 were identified from a prospec-
tively maintained registry. Health systems charts and med-
ical correspondences were reviewed. Measured outcomes
included resolution of the indication for intervention, ad-
ditional procedures, and survival at 30 days and 1 year.
Results: 55 patients were treated with TEVAR for type
B dissection (mean age, 6114 years), 39 (71%) for acute
dissections and 16 (29%) for chronic dissections. Indica-
tions for treatment were pain (21), malperfusion (13),
aneurysm (6), uncontrolled hypertension (6), expansion
(5), and rupture (4). Success, defined by relief of indication
and freedom from death or re-intervention at 30 days, was
achieved in 87% of patients. Twenty-six additional proce-
dures were performed in 22 patients prior to, or at the time
of TEVAR. These included debranching procedures (8),
renal stenting (7), Iliac stenting (5), iliac exposure or
conduit creation (2), mesenteric stenting (2), thrombec-
tomy (1), and tube thoracostomy (1). Left subclavian ar-
tery coverage was required in 23 patients. Spinal ischemia
occurred in 4 patients, and lumbar drainage performed in 2
patients. Three patients required reintervention during the
study period. Survival was 93% at thirty-days and 78% at
one year.
Conclusions: TEVAR is effective in the treatment of
the complications of both acute and chronic type B aortic
dissection. Additional procedures are frequently necessary,
but early results indicate favorable outcomes, while re-
intervention is rare.
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Objectives: Although dextran has been theorized to
diminish the risk of stroke after carotid endarterectomy-
(CEA) variation exists in its use. We evaluated outcomes of
dextran use in patients undergoing CEA to clarify its utility.
Methods: We studied all primary CEA performed by
71 surgeons within the Vascular Study Group of New
England database (2003-2010). Patients were stratified by
perioperative dextran use. Outcomes included periopera-
tive death, stroke, myocardial infarction(MI) and conges-
tive heart failure(CHF). Group and propensity score
matching were performed for risk adjusted comparisons,
and multivariable logistic regression was used to examine
associations between dextran use and outcomes.
Results: There were 6,641 CEA performed, with dex-
tran used in 334(5%) procedures. Dextran and No Dextran
patients were similar in age(70 years) and symptomatic
status(25%). Other differences between the cohorts dimin-
ished after adjustment (Table). In crude, group-matched,
and propensity matched analyses, stroke/death rate was
similar between cohorts (1.2%),while Dextran patients
were more likely to suffer perioperative MI (2.4% vs 1.0%;
Table.
EVAR OAR
Male (n1820) Female (n453) P value Male (n1436) Female (n484) P value
Age (years), median
All 74 77 .001 71 73 .001
Intact 74 76 .001 70 73 .001
Ruptured 72 78 .001 73 77 .001
AAA diameter (mm), mean
All 58.4 56.6 .004 64.7 59.7 .001
Elective 57.2 55.4 .001 60.8 57.3 .001
Symptomatic 65.4 62.5 0.39 69.3 65.4 .24
Ruptured 75.3 72.4 0.56 79.1 70.8 .004
30-day mortality (%)
All 2 2 0.46 8 9 .39
Intact 1 1 .58 2 4 .05
Ruptured 29 26 1.00 33 48 .03
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